BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 31336723)

  • 1. Ligand Binding and Signaling of HARE/Stabilin-2.
    Harris EN; Cabral F
    Biomolecules; 2019 Jul; 9(7):. PubMed ID: 31336723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyaluronic acid receptor for endocytosis (HARE)-mediated endocytosis of hyaluronan, heparin, dermatan sulfate, and acetylated low density lipoprotein (AcLDL), but not chondroitin sulfate types A, C, D, or E, activates NF-κB-regulated gene expression.
    Pandey MS; Weigel PH
    J Biol Chem; 2014 Jan; 289(3):1756-67. PubMed ID: 24247245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A hyaluronan receptor for endocytosis (HARE) link domain N-glycan is required for extracellular signal-regulated kinase (ERK) and nuclear factor-κB (NF-κB) signaling in response to the uptake of hyaluronan but not heparin, dermatan sulfate, or acetylated low density lipoprotein (LDL).
    Pandey MS; Weigel PH
    J Biol Chem; 2014 Aug; 289(32):21807-17. PubMed ID: 24942734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ligand-binding profile of HARE: hyaluronan and chondroitin sulfates A, C, and D bind to overlapping sites distinct from the sites for heparin, acetylated low-density lipoprotein, dermatan sulfate, and CS-E.
    Harris EN; Weigel PH
    Glycobiology; 2008 Aug; 18(8):638-48. PubMed ID: 18499864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic Glycosaminoglycan Clearance by HARE/Stabilin-2 Activates Intracellular Signaling.
    Weigel PH
    Cells; 2020 Oct; 9(11):. PubMed ID: 33126404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The hyaluronan receptor for endocytosis (HARE) activates NF-κB-mediated gene expression in response to 40-400-kDa, but not smaller or larger, hyaluronans.
    Pandey MS; Baggenstoss BA; Washburn J; Harris EN; Weigel PH
    J Biol Chem; 2013 May; 288(20):14068-14079. PubMed ID: 23530033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-Glycans on the link domain of human HARE/Stabilin-2 are needed for hyaluronan binding to purified ecto-domain, but not for cellular endocytosis of hyaluronan.
    Harris EN; Parry S; Sutton-Smith M; Pandey MS; Panico M; Morris HR; Haslam SM; Dell A; Weigel PH
    Glycobiology; 2010 Aug; 20(8):991-1001. PubMed ID: 20466649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stabilin-1 and Stabilin-2 are specific receptors for the cellular internalization of phosphorothioate-modified antisense oligonucleotides (ASOs) in the liver.
    Miller CM; Donner AJ; Blank EE; Egger AW; Kellar BM; Østergaard ME; Seth PP; Harris EN
    Nucleic Acids Res; 2016 Apr; 44(6):2782-94. PubMed ID: 26908652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of the Liver Hyaluronan Receptor for Endocytosis (HARE) and Its Progressive Emergence as the Multi-Ligand Scavenger Receptor Stabilin-2.
    Weigel PH
    Biomolecules; 2019 Sep; 9(9):. PubMed ID: 31500161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stabilin-1 and stabilin-2 are both directed into the early endocytic pathway in hepatic sinusoidal endothelium via interactions with clathrin/AP-2, independent of ligand binding.
    Hansen B; Longati P; Elvevold K; Nedredal GI; Schledzewski K; Olsen R; Falkowski M; Kzhyshkowska J; Carlsson F; Johansson S; Smedsrød B; Goerdt S; Johansson S; McCourt P
    Exp Cell Res; 2005 Feb; 303(1):160-73. PubMed ID: 15572036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the Hyaluronan Receptor, Stabilin-2/HARE, in Health and Disease.
    Harris EN; Baker E
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32429122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stabilin-1, a homeostatic scavenger receptor with multiple functions.
    Kzhyshkowska J; Gratchev A; Goerdt S
    J Cell Mol Med; 2006; 10(3):635-49. PubMed ID: 16989725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression, processing, and glycosaminoglycan binding activity of the recombinant human 315-kDa hyaluronic acid receptor for endocytosis (HARE).
    Harris EN; Kyosseva SV; Weigel JA; Weigel PH
    J Biol Chem; 2007 Feb; 282(5):2785-97. PubMed ID: 17145755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The human hyaluronan receptor for endocytosis (HARE/Stabilin-2) is a systemic clearance receptor for heparin.
    Harris EN; Weigel JA; Weigel PH
    J Biol Chem; 2008 Jun; 283(25):17341-50. PubMed ID: 18434317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rat and human HARE/stabilin-2 are clearance receptors for high- and low-molecular-weight heparins.
    Harris EN; Baggenstoss BA; Weigel PH
    Am J Physiol Gastrointest Liver Physiol; 2009 Jun; 296(6):G1191-9. PubMed ID: 19359419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The hyaluronan receptor for endocytosis mediates hyaluronan-dependent signal transduction via extracellular signal-regulated kinases.
    Kyosseva SV; Harris EN; Weigel PH
    J Biol Chem; 2008 May; 283(22):15047-55. PubMed ID: 18387958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of ERK and NF-κB during HARE-Mediated Heparin Uptake Require Only One of the Four Endocytic Motifs.
    Pandey MS; Miller CM; Harris EN; Weigel PH
    PLoS One; 2016; 11(4):e0154124. PubMed ID: 27100626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid plasma membrane-endosomal trafficking of the lymph node sinus and high endothelial venule scavenger receptor/homing receptor stabilin-1 (FEEL-1/CLEVER-1).
    Prevo R; Banerji S; Ni J; Jackson DG
    J Biol Chem; 2004 Dec; 279(50):52580-92. PubMed ID: 15345716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue-specific splice variants of HARE/Stabilin-2 are expressed in bone marrow, lymph node, and spleen.
    Hare AK; Harris EN
    Biochem Biophys Res Commun; 2015 Jan; 456(1):257-61. PubMed ID: 25446080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The endothelial cell receptor stabilin-2 regulates VWF-FVIII complex half-life and immunogenicity.
    Swystun LL; Lai JD; Notley C; Georgescu I; Paine AS; Mewburn J; Nesbitt K; Schledzewski K; Géraud C; Kzhyshkowska J; Goerdt S; Hopman W; Montgomery RR; James PD; Lillicrap D
    J Clin Invest; 2018 Aug; 128(9):4057-4073. PubMed ID: 30124466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.